DE69333673D1 - Epitope von Stress Proteinen - Google Patents

Epitope von Stress Proteinen

Info

Publication number
DE69333673D1
DE69333673D1 DE69333673T DE69333673T DE69333673D1 DE 69333673 D1 DE69333673 D1 DE 69333673D1 DE 69333673 T DE69333673 T DE 69333673T DE 69333673 T DE69333673 T DE 69333673T DE 69333673 D1 DE69333673 D1 DE 69333673D1
Authority
DE
Germany
Prior art keywords
purified
epitope
epitopes
stress proteins
synthesised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333673T
Other languages
English (en)
Other versions
DE69333673T2 (de
Inventor
James Peter Burnie
Ruth Christine Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Publication of DE69333673D1 publication Critical patent/DE69333673D1/de
Application granted granted Critical
Publication of DE69333673T2 publication Critical patent/DE69333673T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69333673T 1992-08-18 1993-08-17 Epitope von Stress Proteinen Expired - Lifetime DE69333673T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9217542A GB2270076A (en) 1992-08-18 1992-08-18 Human HSP 90 Epitopes
GB9217542 1992-08-18

Publications (2)

Publication Number Publication Date
DE69333673D1 true DE69333673D1 (de) 2004-11-25
DE69333673T2 DE69333673T2 (de) 2006-03-09

Family

ID=10720544

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69333673T Expired - Lifetime DE69333673T2 (de) 1992-08-18 1993-08-17 Epitope von Stress Proteinen
DE69328489T Expired - Lifetime DE69328489T2 (de) 1992-08-18 1993-08-17 Stress-proteine epitopen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69328489T Expired - Lifetime DE69328489T2 (de) 1992-08-18 1993-08-17 Stress-proteine epitopen

Country Status (12)

Country Link
US (1) US5777083A (de)
EP (2) EP0656945B1 (de)
JP (1) JP3439213B2 (de)
AT (2) ATE192192T1 (de)
AU (1) AU4727593A (de)
DE (2) DE69333673T2 (de)
DK (2) DK0656945T3 (de)
ES (2) ES2231907T3 (de)
GB (1) GB2270076A (de)
GR (1) GR3033809T3 (de)
PT (2) PT656945E (de)
WO (1) WO1994004676A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
EP0739981A1 (de) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable Fragmente von Immunglobulinen-Verwendung zur therapeutischen oder veterinären Zwecken
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
CA2242911A1 (en) 1996-01-16 1997-07-24 Kay C. Dee Peptides for altering osteoblast adhesion
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
EP1829551B1 (de) 1998-02-20 2010-09-29 University of Miami Modifizierter Hitzeschockprotein-Antigenpeptid-Komplex
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
WO2001091787A1 (en) 2000-06-02 2001-12-06 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
US7491702B2 (en) 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US7666581B2 (en) 2001-08-20 2010-02-23 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease
DE10161051B4 (de) * 2001-12-12 2005-09-15 Wieland, Heinrich, Prof. Dr. Diagnose der Malaria
US7959915B2 (en) 2003-03-12 2011-06-14 Tufts University Inhibitors of extracellular Hsp90
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
EP1806582B1 (de) * 2006-01-04 2011-05-11 Industrial Technology Research Institute Verfahren zur Diagnose von Myasthenia gravis
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2007098229A2 (en) * 2006-02-21 2007-08-30 Michigan State University Geldanamycin derivatives and method of use thereof
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
JP2011513399A (ja) 2008-03-03 2011-04-28 ザ ユニバーシティー オブ マイアミ 同種癌細胞による免疫療法
EP2274001A4 (de) 2008-03-20 2012-08-01 Univ Miami Impfung mit hitzeschockprotein gp96 und anwendungsverfahren dafür
CA2759370C (en) 2009-04-30 2020-02-11 Peter Schotte Method for the production of domain antibodies
JP6744318B2 (ja) 2015-02-06 2020-08-26 ヒート バイオロジクス，インコーポレイテッド ワクチンおよび共刺激分子を共発現するベクター
WO2018071405A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
CA3058938A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915019D0 (en) * 1989-06-30 1989-08-23 Matthews Ruth C Medicaments
US5188964A (en) * 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
GB9016315D0 (en) * 1990-07-25 1990-09-12 Burnie James P Medicaments
DE4201181A1 (de) * 1992-01-17 1993-07-22 Boehringer Mannheim Gmbh Verfahren zur stabilisierung von proteinen

Also Published As

Publication number Publication date
JPH08500016A (ja) 1996-01-09
GR3033809T3 (en) 2000-10-31
GB9217542D0 (en) 1992-09-30
JP3439213B2 (ja) 2003-08-25
GB2270076A (en) 1994-03-02
US5777083A (en) 1998-07-07
ATE280227T1 (de) 2004-11-15
ATE192192T1 (de) 2000-05-15
AU4727593A (en) 1994-03-15
WO1994004676A1 (en) 1994-03-03
DK0861892T3 (da) 2005-02-14
EP0861892A1 (de) 1998-09-02
PT656945E (pt) 2000-08-31
EP0656945B1 (de) 2000-04-26
EP0861892B1 (de) 2004-10-20
EP0656945A1 (de) 1995-06-14
DK0656945T3 (da) 2000-09-11
ES2231907T3 (es) 2005-05-16
PT861892E (pt) 2005-03-31
DE69328489T2 (de) 2000-11-30
DE69328489D1 (de) 2000-05-31
DE69333673T2 (de) 2006-03-09
ES2147560T3 (es) 2000-09-16

Similar Documents

Publication Publication Date Title
ATE280227T1 (de) Epitope von stress proteinen
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
FI895382A0 (fi) Uretan-skyddade aminosyra-n -karboxianhydrider.
ATE138102T1 (de) Verfahren zur herstellung von cysteinfreien peptiden
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ES2044950T3 (es) Un procedimiento para producir una proteina.
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum

Legal Events

Date Code Title Description
8364 No opposition during term of opposition